US Patent Issued to Xavier University of Louisiana on March 25 for "S6K1 protein kinase inhibitors as cancer therapeutics" (Louisiana Inventors)

ALEXANDRIA, Va., March 26 -- United States Patent no. 12,258,315, issued on March 25, was assigned to Xavier University of Louisiana (New Orleans).

"S6K1 protein kinase inhibitors as cancer therapeutics" was invented by Jayalakshmi Sridhar (New Orleans), Melyssa Bratton (New Orleans) and Rajesh Komati (Thibodaux, La.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to compounds that act as protein kinase inhibitors, especially RPS6K1 and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ and/or HER2+ breast cancer, prostate ...